Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression
Zhang Li(Shanghai Institute of Nutrition and Health), Yuexiang Wang(Shanghai Institute of Nutrition and Health), Xufen Zheng(Shanghai Institute of Nutrition and Health), Li Zhu(Soochow University), Chenghao Shao(Zhejiang Chinese Medical University), Xiaoxiao Liu(Chinese Academy of Sciences), Ke Li(Xi'an University of Science and Technology), Xiaona Jia(Shanghai Institute of Nutrition and Health), Yuan Lu(Obstetrics and Gynecology Hospital of Fudan University), Xiaojing Lu(Shanghai Jiao Tong University), Simin Wang(Fudan University), Yuzhi Pang(Shanghai Institute of Nutrition and Health), Feifei Xie(Stomatology Hospital)
Cited by 25
Related Papers
Mn<sup>2+</sup> Dopant‐Controlled Synthesis of NaYF<sub>4</sub>:Yb/Er Upconversion Nanoparticles for in vivo Imaging and Drug Delivery
|Advanced Materials|2012|821
Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples
|PLoS ONE|2009|433
Graphdiyne Oxides as Excellent Substrate for Electroless Deposition of Pd Clusters with High Catalytic Activity
|Journal of the American Chemical Society|2015|393